CRISPR Therapeutics CRISPR Therapy Shows 90% Response Rate In Aggressive Blood Cancer

CRISPR Therapeutics shares early autoimmune and lymphoma data for zugo-cel, showing strong responses, manageable safety, and ...

Is the Market Bullish or Bearish on CRISPR Therapeutics AG?

According to Benzinga Pro, CRISPR Therapeutics AG's peer group average for short interest as a percentage of float is 14.28%, ...
Frontiers

Single-Cell CRISPR Perturb-Seq Mapping of Non-Coding Regulatory Elements in Human Disease

Large-scale human genetics studies have shown that many risk variants for common and complex diseases sit in the non-coding ...

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...
Frontiers

Hot topics III—Targeting neurological diseases by gene therapy approaches

Using X-ray diffraction data, James Watson (1928-2025) made the seminal discovery of the double-helical structure of DNA ...